Bone Marrow Hypoplasia Complicating Tacrolimus (FK506) Therapy

International Journal of Hematology

Volumn 79, Issue 2, 2004, Pages 130-132

  Nosari, Annamaria ^a   Marbello, Laura ^a   De Carlis, Luciano G ^a   De Gasperi, Andrea ^a   Muti, Giuliana ^a   Mancini, Valentina ^a   Morra, Enrica ^a  

^a OSPEDALE NIGUARDA CA GRANDA   (Italy)

Author keywords

Bone marrow hypoplasia; Tacrolimus

Indexed keywords

AZATHIOPRINE; FOLIC ACID; GANCICLOVIR; PYRIMETHAMINE SULFADIAZINE; TACROLIMUS;

ACUTE HEPATITIS; ADOLESCENT; ANEMIA; ARTICLE; BLOOD TOXICITY; BONE MARROW BIOPSY; BONE MARROW HYPOPLASIA; BONE MARROW SUPPRESSION; BONE MARROW TOXICITY; CASE REPORT; CLINICAL FEATURE; ERYTHROCYTE APLASIA; ERYTHROCYTE TRANSFUSION; FEMALE; GRAFT REJECTION; HEART TRANSPLANTATION; HEMOLYTIC UREMIC SYNDROME; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; LIVER TOXICITY; LIVER TRANSPLANTATION; NEUTROPENIA; ORGAN TRANSPLANTATION; PANCYTOPENIA; POSTOPERATIVE CARE; THROMBOCYTOPENIA; THROMBOTIC THROMBOCYTOPENIC PURPURA;

EID: 1442286018     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1532/IJH97.E0213     Document Type: Article

References (16)

1. Asante-Korang A, Boyle GI, Webber SA, Miller SA, Fricker J. Experience of FK506 immune suppression in pediatric heart transplantation: a study of long-term adverse effects. J Heart Lung Transplant. 1996;15:415-422.
2. Dobrolet NC, Webber SA, Blatt J, et al. Hematologic abnormalities in children and young adults receiving tacrolimus-based immunosuppression following cardiothoracic transplantation. Pediatr Transplant. 2001;5:125-131.
3. Schmidt R, Venkat K, Dumler F. Hemolytic-uremic syndrome in a renal transplant recipient on FK506 immunosuppression. Tranplant Proc. 1991;23:3156-3157.
4. Holmann MJ, Gonwa TA, Cooper B, et al. FK506-associated thrombotic thrombocytopenic purpura, Transplantation. 1992;55: 205-206.
5. Ichihashi T, Naoe T, Yoshida H. Haemolytic uremic syndrome during FK506 therapy. Lancet. 1992;340:60-61.
6. Mach-Pascual S, Samii K, Beris P. Microangiopathic haemolytic anemia complicating FK506 (Tacrolimus) therapy. Am J Hematol. 1996;52:310-312.
7. Trimarchi HM, Truong LD, Brennan S, Gonzales JM, Suki WN. FK506-associated thrombotic microangiopathy. Transplantation. 1999;67:539-544.
8. Tezcan H, Zimmer W, Fenstermaker R, Herzig GP, Schriber J. Severe cerebellar swelling and thrombotic thrombocytopenic purpura associated with FK506. Bone Marrow Transplant. 1998;21: 105-109.
9. Au WY, Lie AKW, Lam CCK, et al. Tacrolimus (FK506)-induced thrombotic thrombocytopenic purpura after ABO mismatched second liver transplantation: salvage with plasmapheresis and prostacyclin. Haematologica. 2000;85:659-662.
10. Winkler M, Schulze F, Jost U, Ringe B, Pichlmayr R. Anemia associated with FK506 immunosuppression. Lancet. 1993;341:1035-1036.
11. Suzuki S, Osaka Y, Nakai I, et al. Pure red cell aplasia induced by FK506. Transplantation. 1996;61:831-844.
12. Misra S, Moore TB, Ament ME, Busuttl RW, McDiarmid S. Red cell aplasia in children on Tacrolimus after liver transplantation. Transplantation. 1998;65:575-577.
13. de la Serna-Higuera C, Barena Marugan R, Avilés J, Nuno J, Cantalapiedra A. Tacrolimus-induced bone marrow suppression. Lancet. 1997;350:714-715.
14. Peter C, Latta K, Graf D, Offner G, Brodhel J. Does tacrolimus cause more severe anemia than cyclosporine A in children after renal transplantation? Transpl Int. 1998;11(suppl 1):328-330.
15. Marsh JCW, Abboudi ZH, Gibson FM, et al. Aplastic anemia following exposure to 3,4 methylenedioxyamphetamine (Ecstasy). Br J Haematol. 1994;88:281-285.
16. Clarck AD, Butt N. Ecstasy-induced very severe aplastic anaemia complicated by invasive pulmonary mucormycosis treated with allogeneic peripheral blood progenitor cell transplant. Clin Lab Haematol. 1997;19:279-281.